1.30
-0.03 (-2.26%)
-0.03 (-2.26%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aclaris Therapeutics Inc | ACRS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.03 | -2.26% | 1.30 | 1.28 | 1.36 | 1.34 | 1.33 | 14:11:43 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 1.30 | 1.31 | 0.01 | 0.76% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 803 | 208,479 | $ 1.31 | $ 273,087 | 860,398 | 0.74 - 7.51 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:11:43 | 100 | $ 1.30 | USD |
Aclaris Therapeutics Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 53.80M | 41.39M | $ -132.74M | -4.04 | - | 39.60M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Aclaris Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ACRS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.46 | 1.61 | 1.28 | 1.36 | 300,990 | -0.16 | -10.96% |
| 1 Month | 1.67 | 1.74 | 1.20 | 1.42 | 489,110 | -0.37 | -22.16% |
| 3 Months | 1.65 | 2.65 | 1.20 | 1.80 | 601,128 | -0.35 | -21.21% |
| 6 Months | 0.87 | 2.65 | 0.8541 | 1.59 | 1,183,431 | 0.43 | 49.43% |
| 1 Year | 7.44 | 7.51 | 0.74 | 2.35 | 974,665 | -6.14 | -82.53% |
| 3 Years | 28.04 | 33.25 | 0.74 | 8.95 | 545,638 | -26.74 | -95.36% |
| 5 Years | 11.94 | 33.88 | 0.74 | 10.14 | 407,848 | -10.64 | -89.11% |
Aclaris Therapeutics Description
| Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which operates in United States. It focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology. The company holds a drug candidate, A-101 Topical Solution which is a proprietary high-concentration hydrogen peroxide topical solution which is being developed as a prescription treatment for seborrheic keratosis (SK) a common non-malignant skin tumor. Its pipeline of drug candidates includes A-101 as a Topical Solution for treatment of SK, common warts; A-102 as a gel dosage form for treatment of SK and warts and A-201 and A-301 as an oral and topical formulation for treatment of autoimmune dermatologic respectively. |
